Short Interest in Nephros, Inc. (NASDAQ:NEPH) Grows By 133.7%

Nephros, Inc. (NASDAQ:NEPH) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 19,400 shares, a growth of 133.7% from the February 28th total of 8,300 shares. Based on an average daily volume of 13,500 shares, the days-to-cover ratio is currently 1.4 days. Approximately 0.2% of the company’s stock are short sold.

Nephros Price Performance

Shares of Nephros stock opened at $1.67 on Friday. The business has a 50-day simple moving average of $1.57 and a 200 day simple moving average of $1.57. Nephros has a one year low of $1.36 and a one year high of $2.55. The firm has a market capitalization of $17.61 million, a price-to-earnings ratio of -18.56 and a beta of 1.19.

Nephros (NASDAQ:NEPH) last released its quarterly earnings data on Monday, March 24th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.04. Nephros had a negative return on equity of 11.39% and a negative net margin of 6.86%. The firm had revenue of $3.87 million during the quarter, compared to the consensus estimate of $3.67 million.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Nephros stock. Topline Capital Management LLC bought a new position in shares of Nephros, Inc. (NASDAQ:NEPH) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 419,887 shares of the company’s stock, valued at approximately $617,000. Topline Capital Management LLC owned approximately 3.98% of Nephros at the end of the most recent reporting period. Institutional investors and hedge funds own 41.10% of the company’s stock.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.